Novel features in the evolution of adenylosuccinate lyase deficiency. 2012

Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
Department of Neurology, Hospital Sant Joan de Déu, Passeig Sant Joan de Dèu 2, 08950 Esplugues, Barcelona, Spain. bperez@hsjdbcn.org

BACKGROUND Adenylosuccinate lyase (ADSL) deficiency is an autosomal recessive disorder of the purine synthesis which results in accumulation of succinylpurines (succinyladenosine (S-Ado) and succinylamino-imidazole carboxamide riboside (SAICAr)) in body fluids. Patients present developmental delay, often accompanied by epilepsy and autistic spectrum disorders. OBJECTIVE To describe atypical neurological features in the evolution of three novel unrelated cases of ADSL deficiency. METHODS A 9-year-old boy with severe cognitive impairment and autistic behaviour received d-ribose therapy for one year. Drug withdrawal was associated with acute neurological deterioration, severe brain atrophy and demyelination on MRI. The second patient is a 5.5-year-old girl with mild developmental delay who presented a benign course with moderate cognitive impairment as the only feature in her evolution. The final patient is a 14-year-old boy with severe cognitive impairment who developed drug-resistant epilepsy and bathing reflex seizures, progressive spasticity in the lower limbs and thoracic deformity. METHODS SAICAr and S-Ado in urine were analysed by HPLC with diode array detection. Diagnosis was confirmed by molecular analysis of the ADSL gene. RESULTS An elevation of S-Ado and SAICAr excretion in urine was detected in all three patients. The patients were homozygous for the missence change p.I369L and for the novel change p.M389V. CONCLUSIONS Drug-resistant epilepsy and specific therapeutic interventions may modify the neurological outcome in ADSL deficiency. d-ribose must be considered with caution as, in our experience, it returns no clinical benefit and drug withdrawal can precipitate status epilepticus and acute neurological deterioration.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D009128 Muscle Spasticity A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54) Clasp-Knife Spasticity,Spastic,Clasp Knife Spasticity,Spasticity, Clasp-Knife,Spasticity, Muscle
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011686 Purine-Pyrimidine Metabolism, Inborn Errors Dysfunctions in the metabolism of PURINES or PYRIMIDINES resulting from inborn genetic mutations that are inherited or acquired in utero. Purine Pyrimidine Metabolism, Inborn Errors
D011782 Quadriplegia Severe or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or rarely MUSCULAR DISEASES. The locked-in syndrome is characterized by quadriplegia in combination with cranial muscle paralysis. Consciousness is spared and the only retained voluntary motor activity may be limited eye movements. This condition is usually caused by a lesion in the upper BRAIN STEM which injures the descending cortico-spinal and cortico-bulbar tracts. Quadriparesis,Spastic Quadriplegia,Tetraplegia,Flaccid Quadriplegia,Flaccid Tetraplegia,Paralysis, Spinal, Quadriplegic,Spastic Tetraplegia,Flaccid Quadriplegias,Flaccid Tetraplegias,Quadripareses,Quadriplegia, Flaccid,Quadriplegia, Spastic,Quadriplegias,Quadriplegias, Flaccid,Quadriplegias, Spastic,Spastic Quadriplegias,Spastic Tetraplegias,Tetraplegia, Flaccid,Tetraplegia, Spastic,Tetraplegias,Tetraplegias, Flaccid,Tetraplegias, Spastic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002653 Child Behavior Disorders Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns. Childhood Behavior Disorders,Behavior Disorder, Child,Behavior Disorder, Childhood,Child Behavior Disorder,Childhood Behavior Disorder,Disorder, Childhood Behavior

Related Publications

Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
December 2010, Journal of inherited metabolic disease,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
January 2006, Molecular genetics and metabolism,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
March 2015, Journal of inherited metabolic disease,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
April 2013, Journal of magnetic resonance imaging : JMRI,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
January 1994, Advances in experimental medicine and biology,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
January 2000, Prenatal diagnosis,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
May 2001, Journal of child neurology,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
October 2004, Nucleosides, nucleotides & nucleic acids,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
February 2019, Radiology case reports,
Belén Pérez-Dueñas, and Angela Sempere, and Jaume Campistol, and Itziar Alonso-Colmenero, and María Díez, and Verónica González, and Begoña Merinero, and Lourdes R Desviat, and Rafael Artuch
October 2007, Brain & development,
Copied contents to your clipboard!